Acute Severe Ulcerative Colitis with 6 or More Bowel Movements Daily: What to Do When Intravenous Corticosteroids Have Not Worked
Hospitalized patients with acute severe ulcerative colitis who do not respond adequately to first-line intravenous corticosteroid therapy require a clearly defined next step. This protocol addresses that specific transition — when response goals have not been met and escalation is indicated.
The Clinical Scenario
Acute severe UC is defined as 6 or more bowel movements daily accompanied by at least one systemic sign of toxicity: tachycardia, fever, anemia (hemoglobin <10.5 g/dL), or elevated ESR (>30 mm/hr).
When the Previous Treatment Did Not Work
Patients in this scenario were initially treated with intravenous corticosteroids. Response is monitored over 3–5 days using stool frequency, rectal bleeding, and C-reactive protein. When these goals are not reached — stool frequency does not decrease, rectal bleeding persists, or CRP does not fall — escalation to rescue therapy becomes necessary.
Next-Line Approach (Partial Overview)
Patients who fail intravenous corticosteroids are candidates for intravenous medical rescue therapy. Patient-specific factors determine which agent is selected and how the approach is individualized — the full protocol details the agents, selection criteria, and monitoring requirements.
Response Goals
The target is a clinical response by day 7: decreasing stool frequency, absence of rectal bleeding, and a falling C-reactive protein.
References
DOI: 10.14309/ajg.0000000000003463
ASUC is defined as the presence of 6 or more bowel movements daily accompanied by at least one systemic sign of toxicity including tachycardia, fever, anemia (hemoglobin <10.5 g/dL), or elevated inflammatory markers (ESR >30 mm/hr).
In patients with ASUC failing to adequately respond to intravenous corticosteroids (IVCS) by 3 days, we recommend medical rescue therapy with infliximab or cyclosporine.
Response in patients with acute severe UC should be monitored using stool frequency, rectal bleeding, physical examination, vital signs, and serial CRP measurements.
View source ↗